MedTrace Logo

VExUS in Patients With Acute Heart Failure

NCT06397404 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-05-20

No results posted yet for this study

Summary

The importance of assessing venous congestion in heart failure patients is widely acknowledged, but its study is hampered by the lack of a practical evaluation tool. Venous excess ultrasound score (VExUS) is a promising noninvasive ultrasound-guided modality that can detect and objectify clinically significant organ congestion. VExUS congestion grading score was still not formally validated in patients with AHF, as there is limited data on its clinical application in this group of patients.

Conditions

  • Acute Heart Failure

Interventions

DIAGNOSTIC_TEST

Venous excess ultrasound score (VExUS) protocol

All patients upon admission undergo ultrasound assessment of diameter and collapsibility of the inferior vena cava, hepatic vein Doppler, portal vein Doppler, intra-renal venous Doppler.

Sponsors & Collaborators

  • I.M. Sechenov First Moscow State Medical University

    lead OTHER

Principal Investigators

  • Sofia Sovetova · I.M. Sechenov First Moscow State Medical University (Sechenov University)

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-18
Primary Completion
2023-11-25
Completion
2023-12-25

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06397404 on ClinicalTrials.gov